Issued Patents All Time
Showing 1–18 of 18 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12421271 | Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR, 10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid | Klaus Gjervig Jensen, Lisbet Kværnø, Morten Jørgensen, Heidi Lopez de Diego, Frans Dennis Therkelsen | 2025-09-23 |
| 12398169 | Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid | Frans Dennis Therkelsen, Tobias Gylling Frihed | 2025-08-26 |
| 12391650 | Catecholamine prodrugs for use in the treatment of Parkinson's disease | Morten Jørgensen, Erhad Ascic, Klaus Gjervig Jensen, Ask Puschl, Benny Bang-Andersen | 2025-08-19 |
| 12384765 | Catecholamine prodrugs for use in the treatment of Parkinson's Disease | Morten Jørgensen, Klaus Gjervig Jensen, Lisbet Kværnø | 2025-08-12 |
| 12319710 | Catecholamine prodrugs for use in the treatment of Parkinson's diseases | Morten Jørgensen, Klaus Gjervig Jensen | 2025-06-03 |
| 12226428 | Catecholamine prodrugs for use in the treatment of Parkinson's disease | Klaus Gjervig Jensen, Lisbet Kværnø, Morten Jørgensen | 2025-02-18 |
| 12152029 | Crystalline forms of a MAGL inhibitor | Thomas Vetter, Heidi Lopez de Diego, Cheryl A. Grice, John J. M. Wiener, Daniel J. Buzard +6 more | 2024-11-26 |
| 11866410 | Process for the manufacturing of (6AR,10AR)-7-propyl-6,6A,7,8,9,10,10A,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4AR, 10AR)-1-propyl-1,2,3,4,4A,5,10,10A-octahydro-benzo[G]quinoline-6,7-diol | Mikkel Fog Jacobsen, Kåre Søndergaard | 2024-01-09 |
| 11858954 | Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid | Klaus Gjervig Jensen, Lisbet Kværnø, Morten Jørgensen, Heidi Lopez de Diego, Karin Fredholt +3 more | 2024-01-02 |
| 11851456 | Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid | Frans Dennis Therkelsen, Tobias Gylling Frihed | 2023-12-26 |
| 11827665 | Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid | Lisbet Kværnø, Mikkel Fog Jacobsen | 2023-11-28 |
| 11707476 | Catecholamine prodrugs for use in the treatment of parkinson's disease | Klaus Gjervig Jensen, Lisbet Kværnø, Morten Jørgensen | 2023-07-25 |
| 11168056 | Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol | Mikkel Fog Jacobsen, Frans Dennis Therkelsen, Kåre Søndergaard, Tobias Gylling Frihed | 2021-11-09 |
| 11130775 | Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid | Klaus Gjervig Jensen, Lisbet Kværnø, Morten Jørgensen, Heidi Lopez de Diego, Karin Fredholt +3 more | 2021-09-28 |
| 11110110 | Catecholamine prodrugs for use in the treatment of Parkinson's disease | Klaus Gjervig Jensen, Lisbet Kværnø, Morten Jørgensen | 2021-09-07 |
| 11111263 | Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid | Frans Dennis Therkelsen, Tobias Gylling Frihed | 2021-09-07 |
| 11104697 | Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid | Lisbet Kværnø, Mikkel Fog Jacobsen | 2021-08-31 |
| 10729710 | Catecholamine prodrugs for use in the treatment of Parkinson's disease | Klaus Gjervig Jensen, Lisbet Kværnø, Morten Jørgensen | 2020-08-04 |